Every 8-K that Universal Health Realty Income Trust (UHT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow UHT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UHT filings page.
Universal Health Realty Income Trust reported higher earnings for the three and six months ended June 30, 2026. For the second quarter, net income was $5.9 million, or $.43 per diluted share, up from $4.5 million, or $.32 per diluted share, including a $724,000 gain on the sale of land. Adjusted for this gain, adjusted net income was $5.2 million, or $.37 per diluted share, and FFO was $12.5 million, or $.90 per diluted share, both above the prior-year quarter.
For the first six months of 2026, net income was $10.9 million, or $.79 per diluted share, with FFO of $24.8 million, or $1.79 per diluted share. The Trust declared and paid a second quarter dividend of $.75 per share ($10.4 million total). Liquidity included a $475 million credit facility maturing September 30, 2028, with $365.6 million outstanding and $109.4 million of available borrowing capacity as of June 30, 2026. The company also advanced its planned $34 million, 80,000 square foot Miller Medical Plaza development in Florida, supported by a 10-year master flex lease on approximately 75% of rentable space.
Universal Health Realty Income Trust reported routine governance and compensation actions. On June 10, 2026, the Board granted restricted stock awards to four executive officers, including 6,247 shares to Chairman and CEO Alan B. Miller and 3,631 shares each to two senior vice presidents. These awards vest on the second anniversary of the grant, with dividends accruing and paid in aggregate on shares that ultimately vest.
The Trust also held its 2026 Annual Meeting of Stockholders, conducted virtually. Stockholders elected two Class I trustees for terms expiring at the 2029 annual meeting, approved on a nonbinding basis the compensation of named executive officers, and ratified KPMG LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Universal Health Realty Income Trust reported higher earnings for the first quarter of 2026. Net income rose to $5.0 million, or $0.36 per diluted share, up from $4.8 million, or $0.34 per diluted share, a year earlier. Total revenues were essentially flat at about $24.5 million.
Funds from operations, a key REIT performance metric, increased to $12.3 million, or $0.88 per diluted share, compared with $11.9 million, or $0.86 per diluted share, helped by lower interest expense and slightly stronger property income. The Trust paid a first quarter dividend of $0.745 per share, totaling about $10.3 million.
The Trust amended its credit agreement in April 2026, expanding borrowing capacity to $475 million with $359.5 million outstanding as of March 31, 2026. It is also developing the Miller Medical Plaza, an 80,000 square foot medical office building in Florida with an estimated cost of $34 million and a 10-year master flex lease covering about 75% of rentable space.
Universal Health Realty Income Trust entered into a First Amendment to its Second Amended and Restated Credit Agreement. The amendment adds a new incremental term loan facility of $50 million, adjusts a key net worth covenant, and updates interest rate mechanics tied to SOFR.
The minimum tangible net worth requirement is now $100 million. The 2026 Incremental Term Loan will bear interest at either SOFR (for one, three, or six months) or the Base Rate, plus a margin based on the Trust’s Total Leverage Ratio. The new term loan will mature on September 30, 2028, matching the existing term loan’s maturity, and a new subsidiary of the Trust has been added as a guarantor.
Universal Health Realty Income Trust reported lower earnings but essentially flat cash-based performance for 2025. For the fourth quarter, net income was $4.3 million, or $0.31 per diluted share, down from $4.7 million or $0.34 a year earlier, mainly due to weaker property-level income, partly offset by lower interest expense.
Full-year 2025 net income was $17.6 million, or $1.27 per diluted share, compared with $19.2 million and $1.39 in 2024. However, funds from operations, which add back depreciation, were stable at $47.7 million or $3.44 per share versus $47.9 million or $3.46. The Trust paid a fourth-quarter dividend of $0.745 per share and $2.960 per share for the year.
As of December 31, 2025, the Trust had $356.2 million outstanding under a $425 million credit agreement, leaving $68.8 million of borrowing capacity. It also began developing an approximately 80,000 square foot medical office building in Palm Beach Gardens, Florida, with an estimated cost of $34 million and a 10-year master lease covering about 75% of the space.
Universal Health Realty Income Trust furnished its third quarter 2025 earnings release under Item 2.02. The company provided the press release as Exhibit 99.1, making its quarterly results publicly available.
This is a routine disclosure that points readers to the full earnings details in the accompanying press release.